相关实验视频

Updated: May 2, 2026

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

来自母体血的cfDNA用于胎儿外体的非侵入性查

¹Center for Reproduction and Genetics, School of Gusu, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Nanjing Medical University Suzhou, Jiangsu, China.

American journal of clinical and experimental immunology

|March 18, 2024

概括

使用无细胞DNA (cfDNA) 的非侵入性产前检测 (NIPT) 正在超越染色体异常,查单基因疾病,这对于预防出生缺陷至关重要.

科学领域:

遗传学遗传学是一个
产科产科产科产科产科
分子生物学分子生物学

背景情况:

产前查正在从超声波和血清标记转向使用无细胞DNA (cfDNA) 的非侵入性产前检测 (NIPT).
尼普特为染色体异常提供了更高的检测率和更低的错误阳性率.
单基因疾病占出生缺陷的很大一部分 (7.5%12%),但目前没有被NIPT查.

研究的目的:

审查NIPT在查单基性疾病方面的最新进展.
强调将单基因疾病查纳入产前护理的重要性.
讨论NIPT在综合性出生缺陷预防中的潜力.

主要方法:

审查关于NIPT技术的当前文献.
对cfDNA分析用于检测单基性疾病的进展进行分析.
综合了关于单基因疾病患病率和影响的数据.

主要成果:

尼普特技术正在不断发展,以准单基因疾病,超越染色体形积分病.
新兴的方法显示出通过cfDNA分析准确检测单基性疾病的希望.
对单基性疾病的NIPT整合可以显著提高出生缺陷查.

结论:

尼普特在查单基因疾病方面具有重大潜力,补充了现有的产前诊断.
将NIPT扩展到包括单基性疾病是改善出生缺陷预防策略的必要条件.
需要进一步的研究和开发,才能充分实施NIPT以进行综合性单一性疾病查.

关键词:

尼普特 (NIPT) 是一家专业的企业.cfDNA DNA 的时间.单源性疾病单源性疾病

更多相关视频

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

Complementary DNA

Complementary DNA